Drug Shortage Report for JAMP-INDAPAMIDE
Report ID | 3805 |
Drug Identification Number | 02373912 |
Brand name | JAMP-INDAPAMIDE |
Common or Proper name | Indapamide |
Company Name | JAMP PHARMA CORPORATION |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | INDAPAMIDE |
Strength(s) | 2.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C03BA |
ATC description | LOW-CEILING DIURETICS, EXCL THIAZIDES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2016-09-15 |
Estimated end date | 2020-12-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2018-12-19 |
Company comments | supply issue |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-03-21 | English | Compare |
v2 | 2017-03-21 | French | Compare |
v3 | 2017-03-21 | English | Compare |
v4 | 2017-03-21 | French | Compare |
v5 | 2017-09-25 | English | Compare |
v6 | 2017-09-25 | English | Compare |
v7 | 2017-09-25 | French | Compare |
v8 | 2018-10-15 | English | Compare |
v9 | 2018-10-15 | French | Compare |
v10 | 2018-12-19 | English | Compare |
v11 | 2018-12-19 | French | Compare |
Showing 1 to 11 of 11